Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVE: Autologous BM-MSC for Chronic Low Back Pain
NCT04759105Phase 2Completed
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Nov 2019
- Primary completion
- Nov 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone-marrow mesenchymal stem cells in intervertebral disc degeneration (DDD), chronic low back pain (CLBP), sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Started Nov 2019; status: completed.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
intervertebral disc degeneration (DDD)chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04759105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04759105.